Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medicine CEO Lars Fruergaard Jørgensen informed lawmakers the organization would look at new talks with insurers regarding the record rates of Wegovy and copyright should they pledge to help keep the medicines on their formularies. Insurers will https://kethek.com/